Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Accumulated Expenses (2022 - 2026)

HeartSciences' Accumulated Expenses history spans 5 years, with the latest figure at $200483.0 for Q1 2026.

  • For Q1 2026, Accumulated Expenses fell 36.53% year-over-year to $200483.0; the TTM value through Jan 2026 reached $200483.0, down 36.53%, while the annual FY2025 figure was $177628.0, 55.41% down from the prior year.
  • Accumulated Expenses reached $200483.0 in Q1 2026 per HSCS's latest filing, up from $160261.0 in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $1.1 million in Q2 2022 to a low of $5096.0 in Q4 2024.
  • Average Accumulated Expenses over 5 years is $478528.4, with a median of $451939.0 recorded in 2022.
  • Peak YoY movement for Accumulated Expenses: crashed 99.34% in 2024, then skyrocketed 3044.84% in 2025.
  • A 5-year view of Accumulated Expenses shows it stood at $890654.0 in 2022, then fell by 13.25% to $772670.0 in 2023, then plummeted by 99.34% to $5096.0 in 2024, then surged by 3044.84% to $160261.0 in 2025, then increased by 25.1% to $200483.0 in 2026.
  • Per Business Quant, the three most recent readings for HSCS's Accumulated Expenses are $200483.0 (Q1 2026), $160261.0 (Q4 2025), and $599287.0 (Q3 2025).